PharmaTher Holdings Ltd (TSE:PHRM) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
PharmaTher Holdings Ltd. has updated investors on the progress of its FDA New Drug Application for Ketamine, with a GDUFA goal date set for October 29, 2024. The FDA has indicated that no additional information is currently needed. The company is also planning for international approvals and novel uses of ketamine, addressing both the U.S. shortage and global medical needs.
For further insights into TSE:PHRM stock, check out TipRanks’ Stock Analysis page.